Edgen Stock·Nov 04 2025, 15:37返回
返回
百時美施貴寶與Dispatch Bio合作開發新型實體瘤CAR T細胞療法
Edgen Stock·Nov 04 2025, 15:37
[1] Dispatch Bio宣布與百時美施貴寶就實體瘤達成臨床供應和合作協議 (https://finance.yahoo.com/news/dispatch-bio-a ...)[2] Dispatch Bio宣布與百時美施貴寶就實體瘤達成臨床供應和合作協議 - Business Wire (https://vertexaisearch.cloud.google.com/groun ...)